The estimated Net Worth of Melissa Lueke is at least $5.68 Milión dollars as of 2 February 2017. Ms Lueke owns over 4,000 units of Meridian Bioscience stock worth over $5,675,402 and over the last 21 years she sold VIVO stock worth over $0.
Ms has made over 4 trades of the Meridian Bioscience stock since 2012, according to the Form 4 filled with the SEC. Most recently she bought 4,000 units of VIVO stock worth $50,360 on 2 February 2017.
The largest trade she's ever made was exercising 21,000 units of Meridian Bioscience stock on 13 December 2012 worth over $713,370. On average, Ms trades about 1,250 units every 37 days since 2003. As of 2 February 2017 she still owns at least 167,071 units of Meridian Bioscience stock.
You can see the complete history of Ms Lueke stock trades at the bottom of the page.
Melissa A. Lueke is the Consultant at Meridian Bioscience.
Ms Lueke is 58, she's been the Consultant of Meridian Bioscience since . There are 6 older and 6 younger executives at Meridian Bioscience. The oldest executive at Meridian Bioscience Inc. is David Phillips, 81, who is the Independent Chairman of the Board.
Melissa's mailing address filed with the SEC is 3471 RIVER HILLS DRIVE, , CINCINNATI, OH, 45244.
Over the last 22 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny a John A Kraeutler. On average, Meridian Bioscience executives and independent directors trade stock every 41 days with the average trade being worth of $424,761. The most recent stock trade was executed by James M. Anderson on 6 January 2023, trading 8,500 units of VIVO stock currently worth $173,230.
Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.
Meridian Bioscience executives and other stock owners filed with the SEC include: